Derma AI Earns CE Mark Approval
The AI dermatology medical device has gained approval for 27 countries within the European Union
PERTH, Australia, May 27, 2021 /PRNewswire/ -- Advanced Human Imaging Limited (ASX: AHI) ("AHI" or the "Company") is pleased to announce the Derma AI embedded in the AHI DermaScan has received CE Mark clearance in the European Union for the dermatology AI component in CompleteScan.
The Derma AI component (DermaScan AI) can accurately classify skin conditions from an image captured on a standard smartphone camera. Using the largest proprietary database of its kind in the world, the Derma AI can classify 588 common or rare skin conditions in 133 categories – including all categories of skin cancer.
In April, AHI announced a significant equity stake in Triage and a deal to integrate Derma AI into the AHI-owned and patented CompleteScan SaaS platform. The integrated product, known as DermaScan, will empower dermatologists, clinicians, physicians, and nurses to get an instant second opinion and better identify dermatologic conditions using only a smartphone.
"This clearance opens up the market significantly for AHI and Triage. The CE mark covers 27 countries in the European Union. More importantly it validates the AI-powered tool as credible option and gives physicians and patients within the EU access to reliable information so they can make an informed decision," said Vlado Bosanac, Chief Executive Officer of AHI. "Once integrated into the CompleteScan platform, the Derma AI will complement our diverse mobile health offering.
"We're excited to have received the CE approval and to soon be in a position to offer the CompleteScan platform to all of Europe through our partnership with AHI," said Tory Jarmin, Chief Executive Officer of Triage. We set out to create the world's most accurate AI engine that could identify skin conditions in an affordable and accessible manner. As we stand today, I am proud to say we have achieved this with Derma AI. We will now add to this with the recent signing of a distribution agreement with SkinHealth Canada to supply more than 2,000 healthcare professionals in Canada with the Derma AI capabilities, which we intend to offer with the CompleteScan, once available, to assist the 2,000 practitioners with a deeper, more robust provision of care capability."
For more information about AHI's technology, please visit: www.advancedhumanimaging.com
For more information on Triage, please visit: www.triage.com
For more information contact:
Chief Executive Officer
Advanced Human Imaging Limited
+1 (212) 845-4242
*This announcement has been approved by the board of Advanced Human Imaging Limited.
View original content to download multimedia:http://www.prnewswire.com/news-releases/derma-ai-earns-ce-mark-approval-301300644.html
SOURCE Advanced Human Imaging
Released May 27, 2021